3 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 3 | 1 | Terminated 1 |
Follow TP protocol: new trials by email Literature Review of TP protocol trials Research Report on TP protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer S-1 and Paclitaxel, Paclitaxel and Cisplatin, 5-FU and Cisplatin - Esophageal Cancer | Phase 2 / Phase 3 | Terminated | Peking University | 4 | 2012-08-01 | 2017-04-07 |
| Paclitaxel and Cisplatin for Thymic Neoplasm paclitaxel and cisplatin - Thymoma, Thymic Carcinoma | Phase 2 | Terminated | Korean Cancer Study Group | 39 | 2008-09-01 | 2013-04-12 |
| Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Paclitaxel, Cisplatin IP - Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Terminated | University of Oklahoma | 21 | 2006-01-01 | 2021-05-19 |
Esophageal Neoplasms (1) · Fallopian Tube Neoplasms (1) · Ovarian Neoplasms (1) · Thymic epithelial tumor (1) · Thymoma (1) · Uterine Neoplasms (1)
Korean Cancer Study Group (1) · Peking University (1) · University of Oklahoma (1)
China (1) · South Korea (1) · United States (1)
Dae Seog Heo, MD, PhD (1) · Joan Walker, MD (1) · Xiaodong Zhang, MD (1)